Paclitaxel-induced acute myocardial infarction: a case report and literature review

GE Kim, AR Ibrahim, D Shalatouni… - BMC Cardiovascular …, 2024 - Springer
Background Paclitaxel is a chemotherapeutic agent commonly used for ovarian, lung, breast
carcinoma, and Kaposi's sarcoma. Its common side effects include hypersensitivity reaction,
bone marrow suppression, and peripheral neuropathy. However, a rare and life-threatening
side effect is paclitaxel-induced myocardial infarction. Case presentation A 71-year-old man
with type 2 diabetes mellitus, hypertension, heavy smoking history, previous coronary artery
disease with percutaneous coronary intervention (PCI) in left anterior descending artery …

[PDF][PDF] Paclitaxel-induced acute myocardial infarction: A case report and literature

GE Kim, AR Ibrahim, D Shalatouni, NH Abouzeid… - assets-eu.researchsquare.com
Background: Paclitaxel is a chemotherapeutic agent commonly used for ovarian, lung,
breast carcinoma, and Kaposi's sarcoma. Its common side effects include hypersensitivity
reaction, bone marrow suppression, and peripheral neuropathy. However, a rare and life-
threatening side effect is paclitaxel-induced myocardial infarction. Case presentation: A man
in his 70s with type 2 diabetes mellitus, hypertension, heavy smoking history, previous
coronary artery disease with stent in left anterior descending artery (LAD), and non-small …
以上显示的是最相近的搜索结果。 查看全部搜索结果